These findings and previous reports suggest that Fn14 (TWEAKR/CD266/TNFRSF12A) could be a potential invasive/metastatic biomarker and therapeutic target in HNSCC and OSCC. The gene discussed is TNFRSF12A; the disease is head and neck squamous cell carcinoma.